SAXI TRADING IVS: Financial statements 2017
CVR: 36921528
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
SAXI TRADING IVS (CVR 36921528) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2017 report amounted to DKK 985. The solvency ratio was 19.8%.
- Gross Profit
- DKK 0
- Profit/Loss
- DKK 0
- Equity
- DKK 985
- Total Assets
- DKK 4,985
Official annual report
Keep an eye on SAXI TRADING IVS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
As of December 1, 2017, Morten Anneberg Johansen is registered as director of SAXI TRADING IVS.
As of December 1, 2017, Peter Winkler Juhl has stepped down as chairman of SAXI TRADING IVS.
On December 1, 2017, the company changed its name from Randrup Health IVS to SAXI TRADING IVS.
SAXI TRADING IVS has published its annual report for 2016. Gross profit came to DKK 0, and the net result was DKK 0.
About SAXI TRADING IVS
SAXI TRADING IVS was a Danish company of the type Iværksætterselskab based in Låsby, founded in 2015. The company has been dissolved on 17 February 2020. The company was registered under the industry Detailhandel med kosmetikvarer og produkter til personlig pleje. The company was previously named Randrup Health IVS. In 2018, the company reported a gross profit of DKK -4,005 and a net result of DKK -4,005 compared with DKK 0 the year before. Equity in the 2018 report amounted to DKK -3,020.